Hot trend.

The use of PET for staging of non-small cell lung cancer (NSCLC), which has increased across the VA System from 53% of cases in 2000 to 93% in 2013. And it’s a good thing as its use in initial staging is associated with significantly lower risk of NSCLC-specific death (HR 0.78). | Vella, JAMA Netw Open 2019